Boston Scientific kept by JMP at market underperform

Boston Scientific Corp. was retained by JMP Securities analyst Robert Faulkner at a market underperform rating with a price target on the stock of $27 per share following news the FDA posted a warning letter regarding the company's manufacturing facility in Quincy, Mass. Boston Scientific shares Tuesday were down $1.23, or 4.53%, at $25.92 on volume of 15,796,900 shares versus the three-month running average of 4,225,830 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.